Genprex Inc (GNPX)
0.371
+0.02
(+6.15%)
USD |
NASDAQ |
Sep 27, 16:00
0.3655
-0.01
(-1.48%)
After-Hours: 20:00
Genprex Cash from Investing (Quarterly): 0.017M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.017M |
| March 31, 2024 | -0.0158M |
| December 31, 2023 | -0.0098M |
| September 30, 2023 | -0.0218M |
| June 30, 2023 | -0.02M |
| March 31, 2023 | -0.0196M |
| December 31, 2022 | -0.02M |
| September 30, 2022 | -0.016M |
| June 30, 2022 | -0.0218M |
| March 31, 2022 | -0.0018M |
| December 31, 2021 | -0.1736M |
| September 30, 2021 | 0.1683M |
| June 30, 2021 | 0.0315M |
| March 31, 2021 | -0.11M |
| December 31, 2020 | -2.342M |
| September 30, 2020 | 0.1527M |
| June 30, 2020 | -0.0113M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.137M |
| December 31, 2019 | -0.0918M |
| September 30, 2019 | 0.0417M |
| June 30, 2019 | -0.8835M |
| March 31, 2019 | -0.0133M |
| December 31, 2018 | -0.0639M |
| September 30, 2018 | -0.0063M |
| June 30, 2018 | -0.0226M |
| March 31, 2018 | -0.0105M |
| December 31, 2017 | -0.0011M |
| September 30, 2017 | -0.0201M |
| June 30, 2017 | -0.0193M |
| March 31, 2017 | -0.023M |
| December 31, 2016 | -0.0176M |
| September 30, 2016 | -0.0671M |
| June 30, 2016 | -0.004M |
| March 31, 2016 | -0.0008M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.342M
Minimum
Dec 2020
0.1683M
Maximum
Sep 2021
-0.13M
Average
-0.0178M
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co Inc | -1.069B |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -0.144M |
| Theriva Biologics Inc | -0.001M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.796M |
| Cash from Financing (Quarterly) | 0.0208M |
| Free Cash Flow | -20.82M |
| Free Cash Flow Per Share (Quarterly) | -2.673 |
| Free Cash Flow Yield | -3.34K% |